Related Experiment Videos
Quantification of beta APP immunoreactive pre-alpha cells in the entorhinal cortex using image analysis
J E McKenzie1, S M Gentleman, G W Roberts
1Department of Psychiatry & Anatomy, Charing Cross and Westminster Medical School, London.
Summary
Quantifying beta-amyloid precursor protein (beta APP) in Alzheimer's disease brain samples is crucial. A new computerized method accurately counts cells containing beta APP, improving reliability over manual methods.
Area of Science:
- Neuroscience
- Neuropathology
- Molecular Biology
Background:
- Alzheimer's disease diagnosis relies on quantifying neuropathological markers.
- Beta-amyloid precursor protein (beta APP) is implicated in Alzheimer's pathogenesis.
- Manual cell counting for beta APP is unreliable and operator-dependent.
Purpose of the Study:
- To develop a reliable method for quantifying cells containing beta APP in human post-mortem brain samples.
- To improve accuracy and efficiency in neuropathological studies of Alzheimer's disease.
Main Methods:
- Utilized immunocytochemistry to identify pre-alpha cells containing beta APP.
- Developed a computerized cell counting program for quantification.
- Validated the protocol on human post-mortem brain samples.
Main Results:
- Achieved high accuracy (>95%) in identifying and quantifying target cells.
- Demonstrated reliable performance for both novice and expert users.
- Established an efficient protocol for beta APP cell quantification.
Conclusions:
- The developed computerized method reliably quantifies cells containing beta APP.
- This approach overcomes limitations of manual counting, enhancing diagnostic accuracy.
- The protocol is adaptable for quantifying other immunocytochemically defined cell populations.